Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1949 1
1950 1
1953 1
1955 1
1960 1
1965 2
1967 5
1968 3
1969 1
1970 1
1971 4
1972 2
1973 5
1974 1
1975 6
1976 8
1977 4
1978 4
1979 5
1980 2
1981 3
1982 3
1983 3
1984 2
1985 1
1988 2
1989 1
1990 1
1991 2
1992 1
1993 1
1994 2
1999 2
2001 1
2003 2
2004 2
2005 1
2006 1
2008 1
2010 1
2011 2
2012 3
2013 1
2014 5
2015 5
2016 3
2017 4
2018 7
2019 7
2020 3
2021 4
2022 6
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: G.-fives
Page 1
Showing results for G.-fives sargenti
Search for G.-Fivos Sargentis instead (1 results)
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M, Littlejohn D, Knauer M, Tondini C, Di Leo A, Colleoni M, Regan MM, Coates AS, Gelber RD, Goldhirsch A; International Breast Cancer Study Group Trial 23-01. Galimberti V, et al. Lancet Oncol. 2018 Oct;19(10):1385-1393. doi: 10.1016/S1470-2045(18)30380-2. Epub 2018 Sep 5. Lancet Oncol. 2018. PMID: 30196031 Clinical Trial.
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U; International Breast Cancer Study Group Trial 23-01 investigators. Galimberti V, et al. Lancet Oncol. 2013 Apr;14(4):297-305. doi: 10.1016/S1470-2045(13)70035-4. Epub 2013 Mar 11. Lancet Oncol. 2013. PMID: 23491275 Free PMC article. Clinical Trial.
Sargenti defended.
Rigby JJ. Rigby JJ. J Am Dent Assoc. 1994 May;125(5):498, 500. doi: 10.14219/jada.archive.1994.0083. J Am Dent Assoc. 1994. PMID: 8195487 No abstract available.
Where is it and how much? Mapping and quantifying elements in single cells.
Malucelli E, Fratini M, Notargiacomo A, Gianoncelli A, Merolle L, Sargenti A, Cappadone C, Farruggia G, Lagomarsino S, Iotti S. Malucelli E, et al. Analyst. 2016 Sep 21;141(18):5221-35. doi: 10.1039/c6an01091a. Epub 2016 Jul 21. Analyst. 2016. PMID: 27441316 Review.
A narrative review for radiation oncologists to implement preoperative partial breast irradiation.
Zerella MA, Zaffaroni M, Ronci G, Dicuonzo S, Rojas DP, Morra A, Gerardi MA, Fodor C, Rondi E, Vigorito S, Penco S, Sargenti M, Baratella P, Vicini E, Morigi C, Kahler-Ribeiro-Fontana S, Galimberti VE, Gandini S, De Camilli E, Renne G, Cattani F, Veronesi P, Orecchia R, Jereczek-Fossa BA, Leonardi MC. Zerella MA, et al. Radiol Med. 2023 Dec;128(12):1553-1570. doi: 10.1007/s11547-023-01706-6. Epub 2023 Aug 31. Radiol Med. 2023. PMID: 37650981 Review.
The engine-driven canal preparation.
Sargenti A. Sargenti A. J Anglocont Dent Soc. 1973 Oct;(29):15-6. J Anglocont Dent Soc. 1973. PMID: 4519252 No abstract available.
Sargenti revisited.
Kamenar AP. Kamenar AP. CDS Rev. 1983 Oct;76(9):24-7. CDS Rev. 1983. PMID: 6577967 No abstract available.
152 results